656 filings
Page 5 of 33
S-3ASR
zl16xl5p4
14 Nov 19
Automatic shelf registration
5:02pm
8-K
mwmiudcm9 u11c9ye
4 Oct 19
Regulation FD Disclosure
8:40am
S-8
whcp397
11 Sep 19
Registration of securities for employees
5:17pm
8-K
xqe54o rkdwdosag8
20 Aug 19
Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
12:00am
8-K
uuetqm
8 Aug 19
Regulation FD Disclosure
4:22pm
8-K
69we2it0
7 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
DEFA14A
hhsgbi9jx
26 Apr 19
Additional proxy soliciting materials
4:39pm
8-K
ma44haes6 2wow0678
5 Apr 19
Other Events
8:30am
8-K
c98jing9
28 Mar 19
Regulation FD Disclosure
8:38am
8-K
d8ro6m 5mox
25 Mar 19
Regulation FD Disclosure
5:16pm
8-K
r2zfa
25 Mar 19
Regulation FD Disclosure
8:30am
424B5
56zfvos6semnbhf
7 Mar 19
Prospectus supplement for primary offering
9:12am
8-K
u92buv2e4 zy
7 Mar 19
Sarepta Therapeutics Announces Proposed $350,000,000 Public Offering of Common Stock
9:00am
8-K
jvlhqmei
5 Mar 19
Departure of Directors or Certain Officers
5:07pm
424B5
crj5o8
5 Mar 19
Prospectus supplement for primary offering
4:34pm
S-3ASR
ubkd fr5d0j
28 Feb 19
Automatic shelf registration
7:38am